Show/Hide Menu
Hide/Show Apps
Logout
Türkçe
Türkçe
Search
Search
Login
Login
OpenMETU
OpenMETU
About
About
Open Science Policy
Open Science Policy
Open Access Guideline
Open Access Guideline
Postgraduate Thesis Guideline
Postgraduate Thesis Guideline
Communities & Collections
Communities & Collections
Help
Help
Frequently Asked Questions
Frequently Asked Questions
Guides
Guides
Thesis submission
Thesis submission
MS without thesis term project submission
MS without thesis term project submission
Publication submission with DOI
Publication submission with DOI
Publication submission
Publication submission
Supporting Information
Supporting Information
General Information
General Information
Copyright, Embargo and License
Copyright, Embargo and License
Contact us
Contact us
An investigation of AKR1B1 and AKR1B10 in gastrointestinal cancers
Download
Thesis_Esin Gülce Seza.pdf
Date
2023-9-07
Author
Seza, Esin Gülce
Metadata
Show full item record
This work is licensed under a
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
.
Item Usage Stats
93
views
142
downloads
Cite This
Aldo-keto reductases (AKRs) are a large family of oxidoreductases that can utilize electrons from NADPH to reduce many substrates. AKR1B1 and AKR1B10 are among the extensively studied human AKRs due to their roles in the polyol pathway and detoxification reactions, respectively. Our previous research has shown that AKR1B1 and AKR1B10 have diverse effects on colorectal cancer. Using ex vivo samples from colon and rectal tumor patients, I have shown that AKR1B1 expression was associated with a stronger mesenchymal phenotype and worse prognosis, while AKR1B10 expression was associated with the activation of metabolic pathways. Next, using hepatocellular carcinoma (HCC) cell lines with differing metabolic characteristics and low endogenous AKR1B10 expression, I aimed to understand the effect of AKR1B10 on metabolic reprogramming. Forced expression of AKR1B10 in the glycolytic cell line SNU423 activated signaling suggesting enhanced fatty acid synthesis and generation of reactive oxygen species. Overexpression of AKR1B10 in the oxidative cell line HuH-7 resulted in low viability and activation of the nutrient sensor AMPK, especially when glucose and glutamine were withdrawn. Untargeted metabolomics of glucose/glutamine starved AKR1B10 expressing HuH-7 revealed for the first time enhanced gluconeogenesis, most likely for biomass generation and a slower TCA cycle, reflecting poor energetics. Metabolic reprogramming and activation of invasion and metastasis are considered among the major hallmarks of cancer. Overall, my data suggests that AKRs may play critical roles in enhancing both metastatic spread and deregulated metabolism, providing a mechanistic basis for their association with poor prognosis in gastrointestinal cancers.
Subject Keywords
Colorectal cancer
,
Hepatocellular carcinoma
,
AKR1B1
,
AKR1B10
URI
https://hdl.handle.net/11511/105505
Collections
Graduate School of Natural and Applied Sciences, Thesis
Citation Formats
IEEE
ACM
APA
CHICAGO
MLA
BibTeX
E. G. Seza, “An investigation of AKR1B1 and AKR1B10 in gastrointestinal cancers,” Ph.D. - Doctoral Program, Middle East Technical University, 2023.